Valuation : Nitto Denko Corporation

Market Cap 2,272B 14.26B 12.24B 11.46B 10.5B 19.77B 1,362B 19.83B 136B 53.06B 687B 53.55B 52.4B P/E 2027 *
15.7x
P/E 2028 * 14.6x
Enterprise Value 1,914B 12.01B 10.31B 9.66B 8.84B 16.66B 1,147B 16.7B 114B 44.7B 578B 45.11B 44.13B EV / Sales 2027 *
1.74x
EV / Sales 2028 * 1.65x
Free-Float
97.11%
Yield 2027 *
1.91%
Yield 2028 * 2.07%
08-24 Tranche Update on Nitto Denko Corporation's Equity Buyback Plan announced on March 30, 2026. CI
08-20 Nitto Denko Corporation's Equity Buyback announced on March 30, 2026, has closed with 15,502,800 shares, representing 2.31% for ¥49,999.99 million. CI
07-28 Nitto Denko Profit Rises 8% in Fiscal Q1 MT
07-28 Nitto Denko Corporation Revises Consolidated Earnings Guidance for the First Half Ending September 30, 2026 and Full Fiscal Year Ending March 31, 2027 CI
07-10 Tranche Update on Nitto Denko Corporation's Equity Buyback Plan announced on March 30, 2026. CI
07-10 Nitto Denko Repurchases 11 Billion Yen Shares in June MT
05-28 Nitto Denko Corporation Provides Earnings Guidance for the Fiscal Year 2028 and Fiscal Year 2030 CI
05-25 INOAC Corporation acquired Portion Transfer of EPDM Rubber Foam Sealing Materials Business of Nitto Denko Corporation from Nitto Denko Corporation. CI
05-12 Tranche Update on Nitto Denko Corporation's Equity Buyback Plan announced on March 30, 2026. CI
04-27 Nitto Denko's Profit Slips 2.7% for Fiscal Year 2025 MT
04-27 Nitto Denko Corporation Reports Earnings Results for the Full Year Ended March 31, 2026 CI
04-26 Nitto Denko Corporation Provides Consolidated Earnings Guidance for the First Half Ending September 30, 2026 and Fiscal Year Ending March 31, 2027 CI
04-26 Nitto Denko Corporation Proposes Dividend for the Year Ended March 31, 2026, Payable on June 22, 2026; Provides Dividend Guidance for the Second Quarter-End and Year-End Period of Fiscal Year Ending March 31, 2027 CI
1 day+1.46%
1 week+3.33%
Current month+4.39%
1 month+0.58%
3 months+10.05%
6 months-3.58%
Current year-6.57%
1 week 3,366
Extreme 3366
3,513
1 month 3,254
Extreme 3254
3,630
Current year 2,882.5
Extreme 2882.5
3,834
1 year 2,882.5
Extreme 2882.5
4,068
3 years 1,829.2
Extreme 1829.2
4,068
5 years 1,478
Extreme 1478
4,068
10 years 823
Extreme 823
4,068
Manager TitleAgeSince
Chief Executive Officer 73 2014-03-31
President 55 2026-03-31
Director of Finance/CFO 64 2017-05-31
Director TitleAgeSince
Director/Board Member 84 2007-05-31
Chairman 73 2026-03-31
Director/Board Member 61 2017-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.46%+3.33%+4.83%+76.09% 14.26B
-1.61%+1.57%+1.97%+58.42% 80.15B
+1.65%+1.65%-1.80%+15.96% 37.61B
+1.19%+4.33%+3.41%-20.07% 38.24B
+0.70%+5.77%-7.32%+16.31% 24.74B
+3.22%+1.80%+27.29%+20.50% 22.38B
+2.75%+2.52%+71.35%+26.54% 22.97B
+0.59%+0.25%-40.55%-38.01% 18.74B
+0.94%+1.18%+54.85%-28.44% 16.02B
+1.64%+3.71%+12.89%-0.34% 14.64B
Average +1.37%+1.51%+12.69%+12.69% 28.98B
Weighted average by Cap. +0.75%+1.69%+9.20%+20.36%

Financials

2027 *2028 *
Net sales 1,099B 6.9B 5.92B 5.54B 5.08B 9.56B 659B 9.59B 65.64B 25.66B 332B 25.9B 25.34B 1,142B 7.17B 6.15B 5.76B 5.27B 9.93B 684B 9.96B 68.19B 26.66B 345B 26.9B 26.32B
Net income 145B 908M 779M 729M 668M 1.26B 86.68B 1.26B 8.64B 3.38B 43.69B 3.41B 3.33B 155B 972M 835M 781M 715M 1.35B 92.85B 1.35B 9.25B 3.62B 46.8B 3.65B 3.57B
Net Debt -358B -2.25B -1.93B -1.81B -1.66B -3.12B -215B -3.13B -21.4B -8.37B -108B -8.44B -8.26B -392B -2.46B -2.11B -1.98B -1.81B -3.41B -235B -3.42B -23.42B -9.16B -118B -9.24B -9.04B
Logo Nitto Denko Corporation
Nitto Denko Corp is a Japan-based company mainly engaged in the industrial tape business, the optronics business and the life science business. The Company operates in three business segments. The Industrial Tapes segment is engaged in the manufacture and sale of basic functional materials such as bonding materials and protective materials, as well as automotive materials. The Optronics segment is engaged in the manufacture and sale of information functional materials, printed circuits and process materials. The Human Life Science segment is engaged in the manufacture and sale of nucleic acid contract manufacturing, nucleic acid synthesis materials, nucleic acid drug discovery, medical-related materials and other life sciences, membranes such as polymer separation membranes, and personal care materials such as functional films for hygiene materials. The Company is also engaged in the manufacture and sale of new businesses and other products.
Employees
26,477
Date Price Change Volume
26-08-28 JP¥3,471.00 +1.46% 2,651,400
26-08-27 JP¥3,421.00 +0.85% 1,784,700
26-08-26 JP¥3,392.00 +0.33% 1,822,900
26-08-25 JP¥3,381.00 -0.76% 1,422,400
26-08-24 JP¥3,407.00 -0.21% 1,119,200
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
3,421.00JPY
Average target price
3,690.91JPY
Spread / Average Target
+7.89%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6988 Stock